We then determined whether heterozygous deletion of Gpr55 is anticonvulsant in the F1.Scn1a+/- mouse model of Dravet syndrome. This evidence concerns the gene GPR55 and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.